Arsenal Capital Partners will acquire Fortrea’s enabling services segment and patient access businesses, according to a news release.
Fortea (Nasdaq: FTRE), a global clinical research organization based in Research Triangle Park, N.C., is divesting its Endpoint Clinical and Fortrea